Cryptocur 200 Nasal Spray New Zealand - English - Medsafe (Medicines Safety Authority)

cryptocur 200 nasal spray

sanofi-aventis new zealand limited - gonadorelin 200ug - nasal spray solution - 200 mcg/dose - active: gonadorelin 200ug

DYLASTINE 125/50 azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dylastine 125/50 azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: glycerol; disodium edetate; phenethyl alcohol; purified water; carmellose sodium; microcrystalline cellulose; polysorbate 80; benzalkonium chloride - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

DYMISTA 125/50 azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dymista 125/50 azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: disodium edetate; purified water; glycerol; microcrystalline cellulose; polysorbate 80; phenethyl alcohol; benzalkonium chloride; carmellose sodium - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

OMNARIS ciclesonide 50 microgram per actuation nasal spray bottle Australia - English - Department of Health (Therapeutic Goods Administration)

omnaris ciclesonide 50 microgram per actuation nasal spray bottle

chiesi australia pty ltd - ciclesonide, quantity: 50 microgram/actuation - spray, nasal - excipient ingredients: potassium sorbate; hypromellose; purified water; microcrystalline cellulose; disodium edetate; carmellose sodium; hydrochloric acid; nitrogen - omnaris nasal spray is indicated for: the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older; and for the treatment of perennial allergic rhinitis in adults and adolescents 12 years of age and older.

Dymista Nasal Spray, 137 micrograms/50 micrograms per actuation, Nasal Spray, Suspension Malta - English - Medicines Authority

dymista nasal spray, 137 micrograms/50 micrograms per actuation, nasal spray, suspension

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - azelastine hydrochloride, fluticasone propionate - nasal spray, suspension - azelastine hydrochloride 137 µg/spray fluticasone propionate 50 µg/spray - nasal preparations

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution Australia - English - Department of Health (Therapeutic Goods Administration)

spravato esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution

janssen-cilag pty ltd - esketamine hydrochloride, quantity: 32.3 mg (equivalent: esketamine, qty 28 mg) - spray, nasal - excipient ingredients: disodium edetate; citric acid monohydrate; water for injections; sodium hydroxide - spravato is indicated for treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,spravato is to be initiated in conjunction with a newly initiated oral antidepressant.

Dymista Nasal Spray, 137 micrograms/50 micrograms per actuation, Nasal Spray, Suspension Malta - English - Medicines Authority

dymista nasal spray, 137 micrograms/50 micrograms per actuation, nasal spray, suspension

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - nasal spray, suspension - azelastine hydrochloride 137 µg/spray fluticasone propionate 50 µg/spray - nasal preparations

BUDAMAX AQUEOUS NASAL SPRAY budesonide 64         microgram/actuation spray bottle Australia - English - Department of Health (Therapeutic Goods Administration)

budamax aqueous nasal spray budesonide 64 microgram/actuation spray bottle

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; polysorbate 80; disodium edetate; hydrochloric acid; purified water; dispersible cellulose; glucose - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

RHINOCORT AQUEOUS NASAL SPRAY budesonide 64       microgram/actuation spray bottle Australia - English - Department of Health (Therapeutic Goods Administration)

rhinocort aqueous nasal spray budesonide 64 microgram/actuation spray bottle

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: glucose; disodium edetate; dispersible cellulose; polysorbate 80; purified water; hydrochloric acid; potassium sorbate - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.